<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-189" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Cryoballoon Pulmonary Vein Catheter Ablation of Atrial Fibrillation</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Yacoub</surname>
            <given-names>Mena</given-names>
          </name>
          <aff>Northside Hospital</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Sheppard</surname>
            <given-names>Robert C.</given-names>
          </name>
          <aff>Northside Hospital/Un of South Florida</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Mena Yacoub declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Robert Sheppard declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>24</day>
          <month>7</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-189.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Atrial fibrillation (AF) is the most common cardiac arrhythmia encountered in the United States. The prevalence of atrial fibrillation dramatically increases with advancing age. The increasing life expectancy of individuals in the United States, in conjunction with the increasing frequency of risk factors associated with atrial fibrillation such as hypertension and obesity, likely will lead to a continued increase in the number of individuals with atrial fibrillation. This activity reviews the pathophysiology of atrial fibrillation, its presentation, and available treatment options and highlights the role of the interprofessional team in the management of this arrhythmia.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Describe the anatomy of the left atrium and pulmonary veins.</p></list-item><list-item><p>Explain the technique for performing pulmonary vein catheter ablation for atrial fibrillation.</p></list-item><list-item><p>Review the complications of catheter pulmonary vein ablation of atrial fibrillation.</p></list-item><list-item><p>Outline the importance of improving care coordination among the interprofessional team to enhance the delivery of care for patients undergoing cryoballoon pulmonary vein catheter ablation for atrial fibrillation.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=189&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=189">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-189.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Atrial fibrillation (AF) is the most common cardiac arrhythmia encountered in the United States with about 3 million people reported being diagnosed with the disorder.<xref ref-type="bibr" rid="article-189.r1">[1]</xref>&#x000a0;The prevalence of atrial fibrillation dramatically increases with advancing age. As our population has enjoyed greater longevity, along with the increasing presence of risk factors known associated with atrial fibrillation such as hypertension and obesity, the incidence and prevalence of AF is expected to continue to increase.<xref ref-type="bibr" rid="article-189.r2">[2]</xref></p>
        <p>There is significant morbidity associated with the development and perpetuation of AF, including stroke, heart failure, cognitive impairment, renal failure, increased mortality&#x000a0;and a negative impact to&#x000a0;the quality of life.<xref ref-type="bibr" rid="article-189.r3">[3]</xref>&#x000a0;As such, controlling the arrhythmia is often essential to patient quality of life and prognosis, but has been difficult to attain.</p>
        <p>Since Haussaiguarre et al. reported that AF most often began in the posterior left atrium surrounding the ostia of the pulmonary veins,<xref ref-type="bibr" rid="article-189.r4">[4]</xref>&#x000a0;pulmonary vein electrical isolation via catheter ablation has been the cornerstone of nonpharmacological treatment of AF. Treatment of AF may be medical or surgical, depending on patient characteristics, duration of disease, symptoms, and patient preference. The two most frequently used energy sources used for ablation are electrocautery (known as&#x000a0;radio-frequency), and cryoenergy,<xref ref-type="bibr" rid="article-189.r5">[5]</xref>;&#x000a0;although other energy sources are being actively investigated for their efficacy and safety. Both methods have been employed during open-heart surgery with equal efficacy.<xref ref-type="bibr" rid="article-189.r6">[6]</xref>&#x000a0;Catheter&#x000a0;radiofrequency&#x000a0;ablation, where electrocautery is delivered to the tip of a steerable wire, has been used to treat cardiac arrhythmias since the 1980s.<xref ref-type="bibr" rid="article-189.r7">[7]</xref>&#x000a0;Catheter cryoablation, where liquid nitrogen is introduced to scar arrhythmic cardiac tissue, was more recently introduced to deliver less severe burns and thus a more controlled degree of&#x000a0;injury.<xref ref-type="bibr" rid="article-189.r7">[7]</xref>&#x000a0;It is most widely used in pediatrics due to the ability to reverse its effects if not applied for a long period due to its slow injury rate.<xref ref-type="bibr" rid="article-189.r8">[8]</xref></p>
        <p>As radio-frequency energy has been the primary energy source used to electrically isolate all four pulmonary veins,<xref ref-type="bibr" rid="article-189.r9">[9]</xref>&#x000a0;an extensive number of ablation lesions&#x000a0;are needed to be delivered by wire to encircle the vein ostia. This posed a challenge of&#x000a0;completely encircling the peri-ostial pulmonary veins to produce complete conduction block, leaving gaps in the ablation lines and less control in the degree of&#x000a0;injury delivered, which could lead to injury to contiguous structures such as the esophagus.<xref ref-type="bibr" rid="article-189.r10">[10]</xref>&#x000a0;In 2012 the FDA approved a multicenter examination of second-generation cryoballoon which is delivered through a catheter over a wire and can deliver a continuous encircling freeze lesion to the left atrial tissue surrounding the ostia of the pulmonary veins, thus being more consistent in ablation delivery and being less prone to gaps in the ablation field.<xref ref-type="bibr" rid="article-189.r11">[11]</xref>&#x000a0;Cryoenergy's greater lesion control should also theoretically have less risk to injure deeper tissues and thus, safer.<xref ref-type="bibr" rid="article-189.r12">[12]</xref>&#x000a0;A large multicenter trial in Europe showed both methods were equally effective in electrically isolating pulmonary veins and were equally effective in preventing recurrent atrial fibrillation.<xref ref-type="bibr" rid="article-189.r13">[13]</xref>&#x000a0;This activity reviews the methodology of catheter cryoballoon ablation using a multicenter examination of second-generation cryoballoon to treat symptomatic AF and its expected outcomes and risks.</p>
      </sec>
      <sec id="article-189.s3" sec-type="Anatomy and Physiology">
        <title>Anatomy and Physiology</title>
        <p>Before outlining methods to produce electrical pulmonary vein isolation an understanding of the left atrium and pulmonary venous anatomy, variants, and anomalies and how it relates to the cardiac conduction system is essential. Oxygenated blood returning to the heart enters the left atrium via pulmonary veins. In 60% of patients, there are 4 distinct pulmonary vein ostia.<xref ref-type="bibr" rid="article-189.r14">[14]</xref>&#x000a0;The most common variant anatomy is a left common pulmonary vein trunk, followed by a right middle pulmonary vein. The right pulmonary veins lie posterior to the right atrium, and the left pulmonary veins are located between the descending aorta and left atrial appendage. The right and left superior pulmonary veins project forward and upward, whereas the right and left inferior pulmonary veins usually project backward&#x000a0;and downward.<xref ref-type="bibr" rid="article-189.r14">[14]</xref>&#x000a0;Extending onto and around the pulmonary veins are sleeves of cardiac tissue originating from the atria and cava. These sleeves are formed by fascicles of fibers running peripherally around the area of the openings of the pulmonary veins, with fibers continuing off these fascicles to immediately surround the ostia forming sphincter-like structures, but also extending somewhat up the veins, contributing to the formation of myocardial sleeves.<xref ref-type="bibr" rid="article-189.r15">[15]</xref>&#x000a0;The coronary sinus drains 85% of the cardiac venous flow into the RA; surrounding this sinus are muscular bundles of fascicles that extend to the LA serving as interatrial electrical conduits.<xref ref-type="bibr" rid="article-189.r15">[15]</xref>&#x000a0;In comparison to left atrial myocytes, it is believed that&#x000a0;pulmonary vein myocytes are prone to arrhythmogenesis secondary to their shorter refractoriness and increased triggered activity, while the muscular sleeves at the atrial-pulmonary venous junction have a propensity for re-entry circuits.<xref ref-type="bibr" rid="article-189.r16">[16]</xref>&#x000a0;In addition, there are also several autonomic ganglia at the pulmonary venous and left atrial junction which&#x000a0;have&#x000a0;been found to spontaneously induce AF in mice introduced with parasympathomimetics, suggesting a hyperactive autonomic system may play a role in AF.<xref ref-type="bibr" rid="article-189.r17">[17]</xref>&#x000a0;Thus, catheter ablation to electrically isolate the pulmonary veins should be able to prevent atrial fibrillation by preventing propagation of ectopic electrical activity into the atrium, reducing the amount of mass available for propagation of the foci, and/or partially interrupting vagal stimulation to the heart.<xref ref-type="bibr" rid="article-189.r18">[18]</xref></p>
      </sec>
      <sec id="article-189.s4" sec-type="Indications">
        <title>Indications</title>
        <p>The primary selection criterion for ablation of atrial fibrillation is symptomatic AF.<xref ref-type="bibr" rid="article-189.r19">[19]</xref>&#x000a0;The 2017 Expert Consensus Document on Catheter Ablation of Atrial fibrillation states as a Class I recommendation, ablation of paroxysmal AF refractory to at least one Class I or III antiarrhythmic medication. There is less consensus for the use of catheter ablation as first-line therapy for paroxysmal or persistent AF, carrying a class IIa recommendation.<xref ref-type="bibr" rid="article-189.r19">[19]</xref>&#x000a0;In long-standing persistent atrial fibrillation, catheter ablation carries a class IIB recommendation, where there is less evidence of its impact on long-term prognosis. For patients with any AF who have not been placed on at least one antiarrhythmic drug, catheter ablation as first-line is still a class II&#x000a0;recommendation.<xref ref-type="bibr" rid="article-189.r19">[19]</xref>&#x000a0;Although the recently reported CABANA trial<xref ref-type="bibr" rid="article-189.r20">[20]</xref>&#x000a0;did show a statistical benefit of catheter ablation as first-line therapy for AF in patients under 75 years and minorities who received the therapy, there was no difference in the 5-year survival or cardiovascular events comparing primary catheter ablation versus antiarrhythmic drug therapy when considered as an intention to treat. Other reasonable indications (Class II recommendations) for ablation of AF include age younger than 75, heart failure, the presence of&#x000a0;hypertrophic cardiomyopathy, tachycardia-bradycardia syndrome to avoid a pacemaker, and competitive athletes.<xref ref-type="bibr" rid="article-189.r19">[19]</xref>&#x000a0;Asymptomatic patients could be candidates after careful discussion and consideration by the patient although there is not sufficient data to indicate a survival benefit. Professionals hope that such data will be forthcoming as the results of the CABANA trial are uncovered.</p>
      </sec>
      <sec id="article-189.s5" sec-type="Contraindications">
        <title>Contraindications</title>
        <p>The presence of a left atrial thrombus is an absolute contraindication to catheter ablation for AF as this may cause embolism of the thrombus into the arterial system. There is no large-scale data yet that has shown catheter ablation of atrial fibrillation mitigates stroke risk. Thus, patients not amenable to anti-coagulation represent a relative contraindication to this procedure.<xref ref-type="bibr" rid="article-189.r19">[19]</xref></p>
      </sec>
      <sec id="article-189.s6" sec-type="Technique or Treatment">
        <title>Technique or Treatment</title>
        <p>Cryoballoon&#x000a0;catheter pulmonary vein electrical isolation is performed along with a full diagnostic cardiac electrophysiology study.&#x000a0;Such procedures are performed&#x000a0;in either a dedicated cardiac electrophysiology laboratory, which is preferred or in a cardiac catheterization laboratory. Either must have a cine-fluoroscopy capability that can save images for review&#x000a0;as well as&#x000a0;a recording system for simultaneous surface 12-lead ECG and multiple intracardiac electrograms. The lab must be able to perform intravenous (IV) contrast dye injections&#x000a0;as well as&#x000a0;record multiple pressure waveforms to facilitate transeptal catheterization. Intracardiac ECHO (ICE) is used extensively to assist in transeptal catheterization&#x000a0;as well as&#x000a0;rule out atrial thrombi and recreate real-time images of the patient&#x02019;s left atrial anatomy.&#x000a0;This can be imported&#x000a0;into a 3-dimensional imaging program to identify variants in left atrial anatomy to guide the procedure. Certain laboratories will&#x000a0;obtain&#x000a0;preoperative CT or MR angiograms, but these are inaccurate unless they&#x000a0;are obtained&#x000a0;in real-time during the procedure as the left atrial volume can&#x000a0;change dramatically&#x000a0;with changes in patient hydration and cardiac rhythm. Intraoperative ECHO can also minimize the need for contrast dye,&#x000a0;and&#x000a0;reports have been published&#x000a0;of completely&#x000a0;fluoro-less&#x000a0;cryoballoon&#x000a0;pulmonary vein isolation.<xref ref-type="bibr" rid="article-189.r21">[21]</xref>&#x000a0;ICE using color flow Doppler can inform the operator of regions of inadequate occlusion at the vein ostia, thus resulting in inadequate freezing of the tissue without&#x000a0;necessitating&#x000a0;repeated venograms to test for adequate circumferential occlusion,&#x000a0;which is&#x000a0;necessary to deliver continuous&#x000a0;cryoinjury&#x000a0;surrounding the pulmonary veins.</p>
        <p>In 2012, the second-generation cryoballoon was approved by the FDA for the use of percutaneous catheter ablation. It has undergone a 2-generation evolution that now comes equipped with an 8-pole circular recording catheter compatible with the balloon. Begin by inserting 5 introducer sheaths via the femoral venous approach. Patients&#x000a0;are premedicated&#x000a0;with oral anticoagulation, either with warfarin or a direct oral anticoagulant, for at least 2 weeks&#x000a0;prior to&#x000a0;the procedure, and the medication is held for a single dose. In the right femoral vein, place an 8-Fr sheath that will act as access for the transeptal sheath, and a 5-Fr sheath that will act as access for a 5-Fr quadripolar&#x000a0;catheter, with 5-mm spacing. The catheter will initially&#x000a0;be placed&#x000a0;in the high right atrium near the RA/SVC border for recording and pacing if the patient is not in atrial fibrillation at the time of the procedure. It can then&#x000a0;be passed&#x000a0;to the junction of the SVC and right subclavian vein to pace the right phrenic nerve during cryoablation to the right pulmonary veins. This allows for monitoring for phrenic nerve injury during application of the balloon to those veins. Three introducer sheaths&#x000a0;are placed&#x000a0;in the left femoral vein acting as access for: (1) a 6-Fr&#x000a0;hexapolar&#x000a0;catheter for recording and locating&#x000a0;the His-bundle site, a fluoroscopic marker of the tricuspid valve anteriorly, helping to locate the fossa ovalis for transeptal access; (2) a 6 Fr&#x000a0;decapolar&#x000a0;catheter to record and pace the coronary sinus; and (3) a pulse wave ICE catheter, which can remain in the right atrium but record anatomy of all cardiac structures.</p>
        <p>If the patient is in sinus rhythm,&#x000a0;a full diagnostic study is performed&#x000a0;first to rule out a reentrant supraventricular tachycardia (SVT) or a concealed accessory pathway.&#x000a0;If none are found, we proceed directly to transseptal catheterization. Start by exchanging the 8-Fr introducer sheath in the right femoral vein for a transseptal sheath, and&#x000a0;utilize&#x000a0;a radiofrequency&#x000a0;transseptal needle to cross the septum posteriorly and somewhat low in the fossa ovalis, to improve the ability to manipulate the&#x000a0;cryoballoon&#x000a0;to the right pulmonary veins when needed. The needle in the transseptal sheath&#x000a0;is exposed&#x000a0;and visualized using ICE and/or fluoroscopy.&#x000a0;Radiofrequency/electrocautery is delivered to 10 watts for 2 seconds when the intracardiac ECHO confirms the proper location. The needle should&#x000a0;be pointing&#x000a0;at the left pulmonary veins when entering the left atrium (see figure). On fluoroscopy in the 30-degree LAO position, the needle will face parallel to the coronary sinus catheter but posterior (away from) to the catheter recording&#x000a0;the His-bundle.</p>
        <p>Patients&#x000a0;are treated&#x000a0;with heparin 1500 IU per hour at the start of the procedure, but once across the septum, the patient immediately receives a heparin bolus of 200 IU/kg, and a continuous drip&#x000a0;is maintained&#x000a0;at 20 IU per hour to assure the ACT&#x000a0;is kept greater than 300 seconds throughout the rest of the procedure.&#x000a0;ACT measurements are drawn&#x000a0;every 15 minutes while any catheter remains across the interatrial septum. The needle&#x000a0;is removed, and a 210-cm&#x000a0;exchange stiff&#x000a0;J-wire is then passed as deep as possible into preferably a superior branch of the left superior pulmonary vein.&#x000a0;The preformed guiding sheath is then removed&#x000a0;leaving the wire in position. If the left superior vein is too difficult to cannulate,&#x000a0;the wire can be placed&#x000a0;deep into the left inferior vein or right superior vein. This way the path across the atrial septum is the straightest when passing the larger&#x000a0;cryoballoon&#x000a0;flex sheath steerable through the fossa.</p>
        <p>The insertion site in the right femoral vein is then gradually enlarged using a 12 Fr introducer and then exchanged over the stainless steel wire with a flat-wire coil and PTFE coating with the larger 14-Fr&#x000a0;cryoballoon&#x000a0;steerable delivery flex sheath. The sheath&#x000a0;is then passed&#x000a0;across the fossa slowly so as not to dislodge the wire from the anchored pulmonary vein. The dilator and sheath can&#x000a0;be steered&#x000a0;up and down to ease the passing through the fossa&#x000a0;ovalis,&#x000a0;which can&#x000a0;be viewed&#x000a0;under fluoroscopy and ICE.&#x000a0;The sheath is then passed&#x000a0;first into the left superior pulmonary vein over the&#x000a0;stainless steel wire with a flat-wire coil and PTFE coating. The tip of the sheath&#x000a0;is positioned&#x000a0;at the PV os, and&#x000a0;the sheath&#x02019;s dilator and the wire are withdrawn, and the sheath is then continuously flushed using an irrigation pump at 2 mL per hr.</p>
        <p>At this point, the appropriately sized&#x000a0;cryoballoon&#x000a0;(either 23 or 28 mm in diameter)&#x000a0;is chosen&#x000a0;based on measurements of the PV ostia diameter taken via ICE. Use the 28-mm balloon universally&#x000a0;except when&#x000a0;one&#x000a0;of the veins&#x000a0;bifurcates&#x000a0;very&#x000a0;shallow preventing the larger balloon from sitting adequately, preventing complete occlusion of&#x000a0;the vein. The&#x000a0;cryoballoon&#x000a0;is then flushed&#x000a0;manually, twice forward&#x000a0;as well as&#x000a0;backward, through the connection, to&#x000a0;ensure&#x000a0;all air-bubbles have been eliminated. The 22-mm diameter mapping loop catheter&#x000a0;is then inserted,&#x000a0;and&#x000a0;the&#x000a0;cryoballoon&#x000a0;is again flushed&#x000a0;manually, twice forward and backward. The balloon&#x000a0;is inserted&#x000a0;into the introducer sheath for only approximately 1 to 3 cm, and then 10 to 20 mL of blood&#x000a0;is withdrawn&#x000a0;from the sheath before further introducing the&#x000a0;cryoballoon, until no air bubbles&#x000a0;are detected,&#x000a0;to completely bathe&#x000a0;the balloon in blood before passing into the sheath further to prevent advancement of air bubbles.</p>
        <p>The&#x000a0;cryoballoon&#x000a0;is then inserted&#x000a0;until its tip is at the tip of the sheath, which can&#x000a0;be denoted&#x000a0;by the indicator on the&#x000a0;cryoballoon&#x000a0;reaching the entrance to the sheath. The 8-pole circular catheter&#x000a0;is then pushed&#x000a0;forward and exposed, and intracardiac&#x000a0;electrogram recordings of the electrical activity of the PV os (PV potentials)&#x000a0;are visualized&#x000a0;(see figure). If the patient is in sinus rhythm, pacing around the vein at 5 mA ensues to confirm baseline PV conduction to the left atrium performed before ablation. After this, the&#x000a0;cryoballoon&#x000a0;is inflated&#x000a0;within the body of the atrium first, and liquid nitrogen&#x000a0;is allowed to&#x000a0;fill the balloon and chill to 0 C, after which it&#x000a0;is then manually deflated&#x000a0;to remove any humidity that may have built up within the balloon or hoses attached. After this, the&#x000a0;cryoballoon&#x000a0;is once again inflated and advanced and pressed against the ostium of the superior PV. A 50/50 mixture of IV dye and saline&#x000a0;is then flushed&#x000a0;into the tip of the balloon to&#x000a0;demonstrate&#x000a0;that no, or minimal, leaks surrounding the balloon are present.&#x000a0;If&#x000a0;complete&#x000a0;occlusion is achieved, keeping constant heavy forward pressure on the balloon,&#x000a0;cryoablation is then initiated. A drop in temperature of 1 C&#x000a0;per second is ideal for the first 30 seconds. At 1 minute of cryoablation,&#x000a0;the end-tidal CO2 (ETCO2)&#x000a0;pressure is measured. Loss of PVP on IEGM recording, a drop of ETCO2 by 4&#x000a0;mm Hg&#x000a0;from baseline, and a nadir temperature of -50 dC all are indicators of&#x000a0;successful,&#x000a0;durable PV electrical isolation (Kroman,&#x000a0;et al). Goal temperature troughs should be less than -40 C as lower temperatures coupled with tighter occlusions are predictive of PVI. A study by Furnkranz&#x000a0;et al&#x000a0;demonstrated&#x000a0;that&#x000a0;a minimal cryoablation temperature of less than -51 C was invariably associated&#x000a0;with PVI. After 120 seconds of freezing, a CBT of equal to -36 C/-33 C (superior/inferior PVs) predicted failed PVI with 97%/95% specificity.<xref ref-type="bibr" rid="article-189.r22">[22]</xref>&#x000a0;If PVPs are eliminated&#x000a0;with 1 minute,&#x000a0;cryoablation is delivered&#x000a0;for 3 minutes. If&#x000a0;they are not eliminated&#x000a0;after 1 minute,&#x000a0;cryoablation is delivered&#x000a0;for 4 minutes.&#x000a0;An additional application for 3 minutes is then delivered,&#x000a0;after allowing the balloon&#x000a0;to thaw following the application that eliminated PV electrical activity fully. A freeze-thaw-freeze approach&#x000a0;is commonly practiced, although a single 240-ms&#x000a0;freezing cycle may also be used. A thaw time of 1 minute or greater&#x000a0;indicates&#x000a0;a successful application to produce PV isolation of that vein.</p>
        <p>During PV cryoablation,&#x000a0;the esophageal temperature is continuously monitored&#x000a0;with an esophageal probe that&#x000a0;is moved&#x000a0;up or down by anesthesia to position the sensor&#x000a0;equidistant to the balloon. Thus, this procedure must&#x000a0;be performed&#x000a0;under general anesthesia with no paralytic agents given so as&#x000a0;not to impact the ability to test phrenic nerve function during cryoablation to the right pulmonary veins.&#x000a0;Cryoablation is performed&#x000a0;stepwise starting with the left superior pulmonary vein, the left inferior pulmonary vein, the right inferior pulmonary and last, the right superior pulmonary vein.&#x000a0;Phrenic nerve function is closely monitored&#x000a0;when delivering cryoablation to the right pulmonary veins because of the&#x000a0;proximity of the path of the right phrenic nerve to the right pulmonary veins ostia. One monitors the right phrenic nerve function using the&#x000a0;quadripolar&#x000a0;right atrial catheter by repositioning the catheter to the junction of the right subclavian vein and superior vena cava and deliver bipolar stimulation at high output pacing at 50 bpm. At the same time, one should use the tactile feel of the abdomen&#x000a0;as well as&#x000a0;C-MAP recording (recording the muscle action potential across the diaphragm through the skin) to monitor the phrenic nerve function during application of cryotherapy to the right pulmonary veins.</p>
        <p>Once all PVPs are confirmed&#x000a0;to&#x000a0;be eliminated&#x000a0;30 minutes after the last application to the veins, if the patient is in sinus rhythm, programmed stimulation&#x000a0;is performed&#x000a0;to atrial refractoriness, and burst at 230&#x000a0;ms&#x000a0;(atrial rate of 260 bpm)&#x000a0;is delivered&#x000a0;at the coronary sinus os to try to re-induce an&#x000a0;atrial&#x000a0;tachyarrhythmias.&#x000a0;If none is induced,&#x000a0;no further ablation is performed. If&#x000a0;an atrial flutter that sustains greater than 10 minutes is induced, we will remove the balloon catheter and insert an 8-mm tip or 3.5-mm tip&#x000a0;irrigation&#x000a0;RF ablation catheter to intracardiac map and ablate the flutter. 3-dimensional&#x000a0;electroanatomic&#x000a0;mapping guides locating the reentrant circuit. If the patient is in sustained AF after PVI, we electrically cardiovert them and assure entrance and exit block at the vein ostia by pacing inside and outside&#x000a0;all the&#x000a0;PVs.</p>
        <p>Once the ablation catheter and sheath&#x000a0;are retracted&#x000a0;into the venous system, anticoagulation is reversed with protamine, but oral anticoagulation continues uninterrupted.</p>
      </sec>
      <sec id="article-189.s7" sec-type="Complications">
        <title>Complications</title>
        <p>In a worldwide survey of 7000 patients who had undergone catheter ablation, complications included cardiac tamponade, thromboembolism causing cerebrovascular accidents, atrioesophageal fistula, pulmonary vein stenosis, and nerve injury-either phrenic or periesophageal vagal nerve.<xref ref-type="bibr" rid="article-189.r23">[23]</xref>&#x000a0;The rate of death was&#x000a0;.98 per 1000 patients. Less prevalent causes of death described in the study included myocardial infarction, torsades de pointes, septicemia, sudden respiratory arrest, extrapericardial pulmonary vein perforation, hemothorax, anaphylaxis, esophageal perforation from an intraoperative esophageal probe, and hematoma formation at the site of entry.<xref ref-type="bibr" rid="article-189.r23">[23]</xref>&#x000a0;Ablation may be proarrhythmic itself and may lead to other tachyarrhythmias post-ablation. Exclusive to cryoballoon ablation and the most common complication is phrenic nerve palsy, due to its proximity to the right superior or inferior pulmonary veins.<xref ref-type="bibr" rid="article-189.r24">[24]</xref>&#x000a0;This can be avoided by immediately stopping delivery of cryo energy, and immediately deflating the balloon by tapping the "stop cryo-ablate" button twice, at the first detection of loss of strength of diaphragmatic excursion by palpation or loss in amplitude of C-MAP on the surface ECG. The rate of pulmonary vein stenosis is less common in cryoablation.<xref ref-type="bibr" rid="article-189.r25">[25]</xref>&#x000a0;Although cryoballoon ablation is considered less technically challenging compared to radiofrequency catheter ablation, more radiation&#x000a0;is often required during cryoablation as cineangiography&#x000a0;is often used to confirm complete PV ostial occlusion by the balloon, necessary for optimal freezing.<xref ref-type="bibr" rid="article-189.r26">[26]</xref></p>
      </sec>
      <sec id="article-189.s8" sec-type="Clinical Significance">
        <title>Clinical Significance</title>
        <p>In the Sustained Treatment of Paroxysmal Atrial Fibrillation (STOP-AF) trial, 245 patients were randomized to either cryoballoon-based PV isolation with the first-generation cryoballoon or antiarrhythmic drug therapy. At 12 months of follow-up, 69.9% of the cryoballoon group versus 7.3% of the drug therapy group, were free of recurrent AF (p &#x0003c; 0.001).<xref ref-type="bibr" rid="article-189.r27">[27]</xref>&#x000a0;Moreover, there was a statistically significant improvement in symptoms and quality of life in the cryoablation group. For all quality-of-life metrics, the improvement was greater in the cryoballoon group when compared to the drug therapy group.<xref ref-type="bibr" rid="article-189.r27">[27]</xref>&#x000a0;In the largest systematic review of studies reporting on cryoballoon PVI ablation for all types of AF, cryoballoon ablation alone (without focal ablation) resulted in PVI in 93% of targeted veins. When using a prespecified exclusive cryoballoon ablation strategy, a 99% complete PVI rate was achieved. The rates were higher in studies using intracardiac or transesophageal echocardiography.<xref ref-type="bibr" rid="article-189.r28">[28]</xref>&#x000a0;Excluding a 3-month blanking period (a time during which episodic arrhythmias are not considered important to long-term recurrences), the 1year freedom from recurrent Atrial Fibrillation was 73%. This is relatively high compared to RF catheter ablation, which has freedom from recurrence rates of 50% to 64%.<xref ref-type="bibr" rid="article-189.r29">[29]</xref></p>
        <p>Because of its historical development,&#x000a0;radiofrequency&#x000a0;ablation is the most frequent method used to perform pulmonary-vein electrical isolation. However,&#x000a0;cryoballoon&#x000a0;ablation is rapidly becoming the more frequently used technology.&#x000a0;One multicenter randomized trial by Kuck et al. comparing radiofrequency ablation to cryoballoon catheter ablation found that cryoballoon ablation was non-inferior to radiofrequency ablation, with primary endpoints including recurrence of atrial fibrillation, occurrence of atrial flutter or atrial tachycardia, use of antiarrhythmic drugs, or repeat ablation occurring in 34.6% in the cryoballoon group versus 35.9% occurring in the radiofrequency group (P&#x0003c;.001). The complication rate in both groups was also non-significant.<xref ref-type="bibr" rid="article-189.r30">[30]</xref>&#x000a0;Additionally,&#x000a0;balloon-based ablation offers a faster means of achieving PVI, that is less reliant on operator skills compared to point-by-point ablation. Cryothermal energy also decreases endothelial disruption lowering thromboembolic risk, and causes minimal tissue contraction with healing, resulting in less PV stenosis and esophageal damage.<xref ref-type="bibr" rid="article-189.r31">[31]</xref></p>
        <p>As expansion of the balloon to a certain size requires ideal pulmonary venous anatomy, cryoablation may not be feasible for every patient with paroxysmal atrial fibrillation. This has been shown in a study by Kubala et al. which demonstrated that patients with a left common ostium had more recurrences compared to normal PV anatomy.<xref ref-type="bibr" rid="article-189.r32">[32]</xref>&#x000a0;In contrast, one study by Khoueiry et al looking at outcomes of cryoablation versus radiofrequency in patients with paroxysmal AF, the authors found no significant difference in the incidence of recurrent atrial fibrillation regardless of pulmonary vein anatomical variation.<xref ref-type="bibr" rid="article-189.r33">[33]</xref>&#x000a0;Additionally, Sorgente et al. reported no significant difference in PV occlusion and longer duration between endpoints in patients with variant anatomy including a left common ostium versus normal discrete left ostia.<xref ref-type="bibr" rid="article-189.r34">[34]</xref>&#x000a0;Thus, the presence of&#x000a0;anatomical variation in patients should not discourage physicians from the use of cryoballoon ablation.&#x000a0;</p>
        <p>In conclusion, cryoballoon&#x000a0;ablation for atrial fibrillation offers an effective, safer, less operator-dependant, means of achieving pulmonary vein isolation, with greater improvement in the quality of life, compared to medical therapy. As such, physicians should present the option to&#x000a0;patients with symptomatic atrial fibrillation, not responding to medical therapy.</p>
      </sec>
      <sec id="article-189.s9" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>An interprofessional&#x000a0;approach to catheter ablation of the pulmonary vein is recommended. Effective communication among specialty trained nurses and clinicians will produce the best outcomes. [Level 5]</p>
        <p>AF is associated with enormous morbidity and mortality, costing billions of healthcare dollars each year. Catheter ablation of the&#x000a0;pulmonary vein is one way to manage symptomatic AF. Primary care providers and nurse practitioners should consult with a cardiologist about the options for treatment of AF patients. Today, catheter ablation has shown good results but a significant number of patients do&#x000a0;develop recurrences, and the procedure is not benign. In any case, catheter ablation remains the choice of symptomatic patients who do not respond to antiarrhythmic drugs.</p>
      </sec>
      <sec id="article-189.s10">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=189&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=189">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/189/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=189">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <floats-group id="article-189.s11">
        <fig id="article-189.image.f1" position="float" orientation="portrait">
          <caption>
            <p>Pulmonary Vein Radiographs and EKG Contributed by Mena Yacoub</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="Yacoub__003" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <ref-list id="article-189.s12">
        <title>References</title>
        <ref id="article-189.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>January</surname>
                <given-names>CT</given-names>
              </name>
              <name>
                <surname>Wann</surname>
                <given-names>LS</given-names>
              </name>
              <name>
                <surname>Alpert</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Calkins</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Cigarroa</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Cleveland</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Conti</surname>
                <given-names>JB</given-names>
              </name>
              <name>
                <surname>Ellinor</surname>
                <given-names>PT</given-names>
              </name>
              <name>
                <surname>Ezekowitz</surname>
                <given-names>MD</given-names>
              </name>
              <name>
                <surname>Field</surname>
                <given-names>ME</given-names>
              </name>
              <name>
                <surname>Murray</surname>
                <given-names>KT</given-names>
              </name>
              <name>
                <surname>Sacco</surname>
                <given-names>RL</given-names>
              </name>
              <name>
                <surname>Stevenson</surname>
                <given-names>WG</given-names>
              </name>
              <name>
                <surname>Tchou</surname>
                <given-names>PJ</given-names>
              </name>
              <name>
                <surname>Tracy</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>Yancy</surname>
                <given-names>CW</given-names>
              </name>
              <collab>American College of Cardiology/American Heart Association Task Force on Practice Guidelines</collab>
            </person-group>
            <article-title>2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society.</article-title>
            <source>J Am Coll Cardiol</source>
            <year>2014</year>
            <month>Dec</month>
            <day>02</day>
            <volume>64</volume>
            <issue>21</issue>
            <fpage>e1</fpage>
            <page-range>e1-76</page-range>
            <pub-id pub-id-type="pmid">24685669</pub-id>
          </element-citation>
        </ref>
        <ref id="article-189.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Miyasaka</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Barnes</surname>
                <given-names>ME</given-names>
              </name>
              <name>
                <surname>Gersh</surname>
                <given-names>BJ</given-names>
              </name>
              <name>
                <surname>Cha</surname>
                <given-names>SS</given-names>
              </name>
              <name>
                <surname>Bailey</surname>
                <given-names>KR</given-names>
              </name>
              <name>
                <surname>Abhayaratna</surname>
                <given-names>WP</given-names>
              </name>
              <name>
                <surname>Seward</surname>
                <given-names>JB</given-names>
              </name>
              <name>
                <surname>Tsang</surname>
                <given-names>TS</given-names>
              </name>
            </person-group>
            <article-title>Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence.</article-title>
            <source>Circulation</source>
            <year>2006</year>
            <month>Jul</month>
            <day>11</day>
            <volume>114</volume>
            <issue>2</issue>
            <fpage>119</fpage>
            <page-range>119-25</page-range>
            <pub-id pub-id-type="pmid">16818816</pub-id>
          </element-citation>
        </ref>
        <ref id="article-189.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Schnabel</surname>
                <given-names>RB</given-names>
              </name>
              <name>
                <surname>Sullivan</surname>
                <given-names>LM</given-names>
              </name>
              <name>
                <surname>Levy</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Pencina</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Massaro</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>D'Agostino</surname>
                <given-names>RB</given-names>
              </name>
              <name>
                <surname>Newton-Cheh</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Yamamoto</surname>
                <given-names>JF</given-names>
              </name>
              <name>
                <surname>Magnani</surname>
                <given-names>JW</given-names>
              </name>
              <name>
                <surname>Tadros</surname>
                <given-names>TM</given-names>
              </name>
              <name>
                <surname>Kannel</surname>
                <given-names>WB</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>TJ</given-names>
              </name>
              <name>
                <surname>Ellinor</surname>
                <given-names>PT</given-names>
              </name>
              <name>
                <surname>Wolf</surname>
                <given-names>PA</given-names>
              </name>
              <name>
                <surname>Vasan</surname>
                <given-names>RS</given-names>
              </name>
              <name>
                <surname>Benjamin</surname>
                <given-names>EJ</given-names>
              </name>
            </person-group>
            <article-title>Development of a risk score for atrial fibrillation (Framingham Heart Study): a community-based cohort study.</article-title>
            <source>Lancet</source>
            <year>2009</year>
            <month>Feb</month>
            <day>28</day>
            <volume>373</volume>
            <issue>9665</issue>
            <fpage>739</fpage>
            <page-range>739-45</page-range>
            <pub-id pub-id-type="pmid">19249635</pub-id>
          </element-citation>
        </ref>
        <ref id="article-189.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ha&#x000ef;ssaguerre</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Ja&#x000ef;s</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Shah</surname>
                <given-names>DC</given-names>
              </name>
              <name>
                <surname>Takahashi</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Hocini</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Quiniou</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Garrigue</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Le Mouroux</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Le M&#x000e9;tayer</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Cl&#x000e9;menty</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins.</article-title>
            <source>N Engl J Med</source>
            <year>1998</year>
            <month>Sep</month>
            <day>03</day>
            <volume>339</volume>
            <issue>10</issue>
            <fpage>659</fpage>
            <page-range>659-66</page-range>
            <pub-id pub-id-type="pmid">9725923</pub-id>
          </element-citation>
        </ref>
        <ref id="article-189.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Brick</surname>
                <given-names>AV</given-names>
              </name>
              <name>
                <surname>Braile</surname>
                <given-names>DM</given-names>
              </name>
            </person-group>
            <article-title>Surgical Ablation of Atrial Fibrillation Using Energy Sources.</article-title>
            <source>Braz J Cardiovasc Surg</source>
            <year>2015</year>
            <season>Nov-Dec</season>
            <volume>30</volume>
            <issue>6</issue>
            <fpage>636</fpage>
            <page-range>636-43</page-range>
            <pub-id pub-id-type="pmid">26934404</pub-id>
          </element-citation>
        </ref>
        <ref id="article-189.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Garg</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Chaudhary</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Palaniswamy</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Shah</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Krishnamoorthy</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Bozorgnia</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Natale</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Cryoballoon versus Radiofrequency Ablation for Atrial Fibrillation: A Meta-analysis of 16 Clinical Trials.</article-title>
            <source>J Atr Fibrillation</source>
            <year>2016</year>
            <season>Oct-Nov</season>
            <volume>9</volume>
            <issue>3</issue>
            <fpage>1429</fpage>
            <pub-id pub-id-type="pmid">28496925</pub-id>
          </element-citation>
        </ref>
        <ref id="article-189.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Goel</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Anderson</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Slaton</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Schmidlin</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Vercellotti</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Belcher</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Bischof</surname>
                <given-names>JC</given-names>
              </name>
            </person-group>
            <article-title>Adjuvant approaches to enhance cryosurgery.</article-title>
            <source>J Biomech Eng</source>
            <year>2009</year>
            <month>Jul</month>
            <volume>131</volume>
            <issue>7</issue>
            <fpage>074003</fpage>
            <pub-id pub-id-type="pmid">19640135</pub-id>
          </element-citation>
        </ref>
        <ref id="article-189.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Barnett</surname>
                <given-names>AS</given-names>
              </name>
              <name>
                <surname>Bahnson</surname>
                <given-names>TD</given-names>
              </name>
              <name>
                <surname>Piccini</surname>
                <given-names>JP</given-names>
              </name>
            </person-group>
            <article-title>Recent Advances in Lesion Formation for Catheter Ablation of Atrial Fibrillation.</article-title>
            <source>Circ Arrhythm Electrophysiol</source>
            <year>2016</year>
            <month>May</month>
            <volume>9</volume>
            <issue>5</issue>
            <pub-id pub-id-type="pmid">27103088</pub-id>
          </element-citation>
        </ref>
        <ref id="article-189.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wittkampf</surname>
                <given-names>FH</given-names>
              </name>
              <name>
                <surname>Derksen</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Wever</surname>
                <given-names>EF</given-names>
              </name>
              <name>
                <surname>Simmers</surname>
                <given-names>TA</given-names>
              </name>
              <name>
                <surname>Boersma</surname>
                <given-names>LV</given-names>
              </name>
              <name>
                <surname>Vonken</surname>
                <given-names>EP</given-names>
              </name>
              <name>
                <surname>Velthuis</surname>
                <given-names>BK</given-names>
              </name>
              <name>
                <surname>Sreeram</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Rensing</surname>
                <given-names>BJ</given-names>
              </name>
              <name>
                <surname>Cramer</surname>
                <given-names>MJ</given-names>
              </name>
            </person-group>
            <article-title>Technique of pulmonary vein isolation by catheter ablation.</article-title>
            <source>Neth Heart J</source>
            <year>2002</year>
            <month>May</month>
            <volume>10</volume>
            <issue>5</issue>
            <fpage>241</fpage>
            <page-range>241-244</page-range>
            <pub-id pub-id-type="pmid">25696100</pub-id>
          </element-citation>
        </ref>
        <ref id="article-189.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Katz-Agranov</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Nevah Rubin</surname>
                <given-names>MI</given-names>
              </name>
            </person-group>
            <article-title>Severe esophageal injury after radiofrequency ablation - a deadly complication.</article-title>
            <source>World J Gastroenterol</source>
            <year>2017</year>
            <month>May</month>
            <day>14</day>
            <volume>23</volume>
            <issue>18</issue>
            <fpage>3374</fpage>
            <page-range>3374-3378</page-range>
            <pub-id pub-id-type="pmid">28566899</pub-id>
          </element-citation>
        </ref>
        <ref id="article-189.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ozcan</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Ruskin</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Mansour</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Cryoballoon catheter ablation in atrial fibrillation.</article-title>
            <source>Cardiol Res Pract</source>
            <year>2011</year>
            <volume>2011</volume>
            <fpage>256347</fpage>
            <pub-id pub-id-type="pmid">21747987</pub-id>
          </element-citation>
        </ref>
        <ref id="article-189.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Leila</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Raluca</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Yves</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Dirk</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Bruno</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Cryoablation Versus Radiofrequency Ablation in AVNRT: Same Goal, Different Strategy.</article-title>
            <source>J Atr Fibrillation</source>
            <year>2015</year>
            <season>Jun-Jul</season>
            <volume>8</volume>
            <issue>1</issue>
            <fpage>1220</fpage>
            <pub-id pub-id-type="pmid">27957174</pub-id>
          </element-citation>
        </ref>
        <ref id="article-189.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kuck</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Brugada</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Albenque</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Cryoballoon or Radiofrequency Ablation for Atrial Fibrillation.</article-title>
            <source>N Engl J Med</source>
            <year>2016</year>
            <month>Sep</month>
            <day>15</day>
            <volume>375</volume>
            <issue>11</issue>
            <fpage>1100</fpage>
            <page-range>1100-1</page-range>
            <pub-id pub-id-type="pmid">27626535</pub-id>
          </element-citation>
        </ref>
        <ref id="article-189.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kato</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Lickfett</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Meininger</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Dickfeld</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Wu</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Juang</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Angkeow</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>LaCorte</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Bluemke</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Berger</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Halperin</surname>
                <given-names>HR</given-names>
              </name>
              <name>
                <surname>Calkins</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Pulmonary vein anatomy in patients undergoing catheter ablation of atrial fibrillation: lessons learned by use of magnetic resonance imaging.</article-title>
            <source>Circulation</source>
            <year>2003</year>
            <month>Apr</month>
            <day>22</day>
            <volume>107</volume>
            <issue>15</issue>
            <fpage>2004</fpage>
            <page-range>2004-10</page-range>
            <pub-id pub-id-type="pmid">12681994</pub-id>
          </element-citation>
        </ref>
        <ref id="article-189.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nathan</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Eliakim</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>The junction between the left atrium and the pulmonary veins. An anatomic study of human hearts.</article-title>
            <source>Circulation</source>
            <year>1966</year>
            <month>Sep</month>
            <volume>34</volume>
            <issue>3</issue>
            <fpage>412</fpage>
            <page-range>412-22</page-range>
            <pub-id pub-id-type="pmid">5922708</pub-id>
          </element-citation>
        </ref>
        <ref id="article-189.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Stiles</surname>
                <given-names>MK</given-names>
              </name>
              <name>
                <surname>John</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Wong</surname>
                <given-names>CX</given-names>
              </name>
              <name>
                <surname>Kuklik</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Brooks</surname>
                <given-names>AG</given-names>
              </name>
              <name>
                <surname>Lau</surname>
                <given-names>DH</given-names>
              </name>
              <name>
                <surname>Dimitri</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Roberts-Thomson</surname>
                <given-names>KC</given-names>
              </name>
              <name>
                <surname>Wilson</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>De Sciscio</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Young</surname>
                <given-names>GD</given-names>
              </name>
              <name>
                <surname>Sanders</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Paroxysmal lone atrial fibrillation is associated with an abnormal atrial substrate: characterizing the "second factor".</article-title>
            <source>J Am Coll Cardiol</source>
            <year>2009</year>
            <month>Apr</month>
            <day>07</day>
            <volume>53</volume>
            <issue>14</issue>
            <fpage>1182</fpage>
            <page-range>1182-91</page-range>
            <pub-id pub-id-type="pmid">19341858</pub-id>
          </element-citation>
        </ref>
        <ref id="article-189.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chen</surname>
                <given-names>PS</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>LS</given-names>
              </name>
              <name>
                <surname>Fishbein</surname>
                <given-names>MC</given-names>
              </name>
              <name>
                <surname>Lin</surname>
                <given-names>SF</given-names>
              </name>
              <name>
                <surname>Nattel</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Role of the autonomic nervous system in atrial fibrillation: pathophysiology and therapy.</article-title>
            <source>Circ Res</source>
            <year>2014</year>
            <month>Apr</month>
            <day>25</day>
            <volume>114</volume>
            <issue>9</issue>
            <fpage>1500</fpage>
            <page-range>1500-15</page-range>
            <pub-id pub-id-type="pmid">24763467</pub-id>
          </element-citation>
        </ref>
        <ref id="article-189.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pellman</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Sheikh</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>Atrial fibrillation: mechanisms, therapeutics, and future directions.</article-title>
            <source>Compr Physiol</source>
            <year>2015</year>
            <month>Apr</month>
            <volume>5</volume>
            <issue>2</issue>
            <fpage>649</fpage>
            <page-range>649-65</page-range>
            <pub-id pub-id-type="pmid">25880508</pub-id>
          </element-citation>
        </ref>
        <ref id="article-189.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Calkins</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Hindricks</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Cappato</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>YH</given-names>
              </name>
              <name>
                <surname>Saad</surname>
                <given-names>EB</given-names>
              </name>
              <name>
                <surname>Aguinaga</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Akar</surname>
                <given-names>JG</given-names>
              </name>
              <name>
                <surname>Badhwar</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Brugada</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Camm</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>PS</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>SA</given-names>
              </name>
              <name>
                <surname>Chung</surname>
                <given-names>MK</given-names>
              </name>
              <name>
                <surname>Nielsen</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Curtis</surname>
                <given-names>AB</given-names>
              </name>
              <name>
                <surname>Davies</surname>
                <given-names>DW</given-names>
              </name>
              <name>
                <surname>Day</surname>
                <given-names>JD</given-names>
              </name>
              <name>
                <surname>d'Avila</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>de Groot</surname>
                <given-names>NMSN</given-names>
              </name>
              <name>
                <surname>Di Biase</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Duytschaever</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Edgerton</surname>
                <given-names>JR</given-names>
              </name>
              <name>
                <surname>Ellenbogen</surname>
                <given-names>KA</given-names>
              </name>
              <name>
                <surname>Ellinor</surname>
                <given-names>PT</given-names>
              </name>
              <name>
                <surname>Ernst</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Fenelon</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Gerstenfeld</surname>
                <given-names>EP</given-names>
              </name>
              <name>
                <surname>Haines</surname>
                <given-names>DE</given-names>
              </name>
              <name>
                <surname>Haissaguerre</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Helm</surname>
                <given-names>RH</given-names>
              </name>
              <name>
                <surname>Hylek</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Jackman</surname>
                <given-names>WM</given-names>
              </name>
              <name>
                <surname>Jalife</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Kalman</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Kautzner</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Kottkamp</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Kuck</surname>
                <given-names>KH</given-names>
              </name>
              <name>
                <surname>Kumagai</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Lewalter</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Lindsay</surname>
                <given-names>BD</given-names>
              </name>
              <name>
                <surname>Macle</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Mansour</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Marchlinski</surname>
                <given-names>FE</given-names>
              </name>
              <name>
                <surname>Michaud</surname>
                <given-names>GF</given-names>
              </name>
              <name>
                <surname>Nakagawa</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Natale</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Nattel</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Okumura</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Packer</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Pokushalov</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Reynolds</surname>
                <given-names>MR</given-names>
              </name>
              <name>
                <surname>Sanders</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Scanavacca</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Schilling</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Tondo</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Tsao</surname>
                <given-names>HM</given-names>
              </name>
              <name>
                <surname>Verma</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Wilber</surname>
                <given-names>DJ</given-names>
              </name>
              <name>
                <surname>Yamane</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation: Executive summary.</article-title>
            <source>J Arrhythm</source>
            <year>2017</year>
            <month>Oct</month>
            <volume>33</volume>
            <issue>5</issue>
            <fpage>369</fpage>
            <page-range>369-409</page-range>
            <pub-id pub-id-type="pmid">29021841</pub-id>
          </element-citation>
        </ref>
        <ref id="article-189.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Packer</surname>
                <given-names>DL</given-names>
              </name>
              <name>
                <surname>Mark</surname>
                <given-names>DB</given-names>
              </name>
              <name>
                <surname>Robb</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Monahan</surname>
                <given-names>KH</given-names>
              </name>
              <name>
                <surname>Bahnson</surname>
                <given-names>TD</given-names>
              </name>
              <name>
                <surname>Moretz</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Poole</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Mascette</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Rosenberg</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Jeffries</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Al-Khalidi</surname>
                <given-names>HR</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>KL</given-names>
              </name>
              <collab>CABANA Investigators</collab>
            </person-group>
            <article-title>Catheter Ablation versus Antiarrhythmic Drug Therapy for Atrial Fibrillation (CABANA) Trial: Study Rationale and Design.</article-title>
            <source>Am Heart J</source>
            <year>2018</year>
            <month>May</month>
            <volume>199</volume>
            <fpage>192</fpage>
            <page-range>192-199</page-range>
            <pub-id pub-id-type="pmid">29754661</pub-id>
          </element-citation>
        </ref>
        <ref id="article-189.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Liu</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Palmer</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Outcomes of 200 consecutive, fluoroless atrial fibrillation ablations using a new technique.</article-title>
            <source>Pacing Clin Electrophysiol</source>
            <year>2018</year>
            <month>Nov</month>
            <volume>41</volume>
            <issue>11</issue>
            <fpage>1404</fpage>
            <page-range>1404-1411</page-range>
            <pub-id pub-id-type="pmid">30194724</pub-id>
          </element-citation>
        </ref>
        <ref id="article-189.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>F&#x000fc;rnkranz</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>K&#x000f6;ster</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Chun</surname>
                <given-names>KR</given-names>
              </name>
              <name>
                <surname>Metzner</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Mathew</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Konstantinidou</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Ouyang</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Kuck</surname>
                <given-names>KH</given-names>
              </name>
            </person-group>
            <article-title>Cryoballoon temperature predicts acute pulmonary vein isolation.</article-title>
            <source>Heart Rhythm</source>
            <year>2011</year>
            <month>Jun</month>
            <volume>8</volume>
            <issue>6</issue>
            <fpage>821</fpage>
            <page-range>821-5</page-range>
            <pub-id pub-id-type="pmid">21315836</pub-id>
          </element-citation>
        </ref>
        <ref id="article-189.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cappato</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Calkins</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>SA</given-names>
              </name>
              <name>
                <surname>Davies</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Iesaka</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Kalman</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>YH</given-names>
              </name>
              <name>
                <surname>Klein</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Packer</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Skanes</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation.</article-title>
            <source>Circulation</source>
            <year>2005</year>
            <month>Mar</month>
            <day>08</day>
            <volume>111</volume>
            <issue>9</issue>
            <fpage>1100</fpage>
            <page-range>1100-5</page-range>
            <pub-id pub-id-type="pmid">15723973</pub-id>
          </element-citation>
        </ref>
        <ref id="article-189.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Parikh</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Kowalski</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Comparison of Phrenic Nerve Injury during Atrial Fibrillation Ablation between Different Modalities, Pathophysiology and Management.</article-title>
            <source>J Atr Fibrillation</source>
            <year>2015</year>
            <month>Dec</month>
            <volume>8</volume>
            <issue>4</issue>
            <fpage>1314</fpage>
            <pub-id pub-id-type="pmid">27957229</pub-id>
          </element-citation>
        </ref>
        <ref id="article-189.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Canpolat</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Kocyigit</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Aytemir</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Complications of Atrial Fibrillation Cryoablation.</article-title>
            <source>J Atr Fibrillation</source>
            <year>2017</year>
            <month>Dec</month>
            <volume>10</volume>
            <issue>4</issue>
            <fpage>1620</fpage>
            <pub-id pub-id-type="pmid">29487676</pub-id>
          </element-citation>
        </ref>
        <ref id="article-189.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mujovi&#x00107;</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Marinkovi&#x00107;</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Lenarczyk</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Tilz</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Potpara</surname>
                <given-names>TS</given-names>
              </name>
            </person-group>
            <article-title>Catheter Ablation of Atrial Fibrillation: An Overview for Clinicians.</article-title>
            <source>Adv Ther</source>
            <year>2017</year>
            <month>Aug</month>
            <volume>34</volume>
            <issue>8</issue>
            <fpage>1897</fpage>
            <page-range>1897-1917</page-range>
            <pub-id pub-id-type="pmid">28733782</pub-id>
          </element-citation>
        </ref>
        <ref id="article-189.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Packer</surname>
                <given-names>DL</given-names>
              </name>
              <name>
                <surname>Kowal</surname>
                <given-names>RC</given-names>
              </name>
              <name>
                <surname>Wheelan</surname>
                <given-names>KR</given-names>
              </name>
              <name>
                <surname>Irwin</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Champagne</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Guerra</surname>
                <given-names>PG</given-names>
              </name>
              <name>
                <surname>Dubuc</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Reddy</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Nelson</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Holcomb</surname>
                <given-names>RG</given-names>
              </name>
              <name>
                <surname>Lehmann</surname>
                <given-names>JW</given-names>
              </name>
              <name>
                <surname>Ruskin</surname>
                <given-names>JN</given-names>
              </name>
              <collab>STOP AF Cryoablation Investigators</collab>
            </person-group>
            <article-title>Cryoballoon ablation of pulmonary veins for paroxysmal atrial fibrillation: first results of the North American Arctic Front (STOP AF) pivotal trial.</article-title>
            <source>J Am Coll Cardiol</source>
            <year>2013</year>
            <month>Apr</month>
            <day>23</day>
            <volume>61</volume>
            <issue>16</issue>
            <fpage>1713</fpage>
            <page-range>1713-23</page-range>
            <pub-id pub-id-type="pmid">23500312</pub-id>
          </element-citation>
        </ref>
        <ref id="article-189.r28">
          <label>28</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Andrade</surname>
                <given-names>JG</given-names>
              </name>
              <name>
                <surname>Dubuc</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Guerra</surname>
                <given-names>PG</given-names>
              </name>
              <name>
                <surname>Macle</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Rivard</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Roy</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Talajic</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Thibault</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Khairy</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Cryoballoon ablation for atrial fibrillation.</article-title>
            <source>Indian Pacing Electrophysiol J</source>
            <year>2012</year>
            <month>Mar</month>
            <volume>12</volume>
            <issue>2</issue>
            <fpage>39</fpage>
            <page-range>39-53</page-range>
            <pub-id pub-id-type="pmid">22557842</pub-id>
          </element-citation>
        </ref>
        <ref id="article-189.r29">
          <label>29</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Calkins</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Reynolds</surname>
                <given-names>MR</given-names>
              </name>
              <name>
                <surname>Spector</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Sondhi</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Xu</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Martin</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Williams</surname>
                <given-names>CJ</given-names>
              </name>
              <name>
                <surname>Sledge</surname>
                <given-names>I</given-names>
              </name>
            </person-group>
            <article-title>Treatment of atrial fibrillation with antiarrhythmic drugs or radiofrequency ablation: two systematic literature reviews and meta-analyses.</article-title>
            <source>Circ Arrhythm Electrophysiol</source>
            <year>2009</year>
            <month>Aug</month>
            <volume>2</volume>
            <issue>4</issue>
            <fpage>349</fpage>
            <page-range>349-61</page-range>
            <pub-id pub-id-type="pmid">19808490</pub-id>
          </element-citation>
        </ref>
        <ref id="article-189.r30">
          <label>30</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kuck</surname>
                <given-names>KH</given-names>
              </name>
              <name>
                <surname>F&#x000fc;rnkranz</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Cryoballoon ablation of atrial fibrillation.</article-title>
            <source>J Cardiovasc Electrophysiol</source>
            <year>2010</year>
            <month>Dec</month>
            <volume>21</volume>
            <issue>12</issue>
            <fpage>1427</fpage>
            <page-range>1427-31</page-range>
            <pub-id pub-id-type="pmid">21091966</pub-id>
          </element-citation>
        </ref>
        <ref id="article-189.r31">
          <label>31</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Andrade</surname>
                <given-names>JG</given-names>
              </name>
              <name>
                <surname>Khairy</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Guerra</surname>
                <given-names>PG</given-names>
              </name>
              <name>
                <surname>Deyell</surname>
                <given-names>MW</given-names>
              </name>
              <name>
                <surname>Rivard</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Macle</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Thibault</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Talajic</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Roy</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Dubuc</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Efficacy and safety of cryoballoon ablation for atrial fibrillation: a systematic review of published studies.</article-title>
            <source>Heart Rhythm</source>
            <year>2011</year>
            <month>Sep</month>
            <volume>8</volume>
            <issue>9</issue>
            <fpage>1444</fpage>
            <page-range>1444-51</page-range>
            <pub-id pub-id-type="pmid">21457789</pub-id>
          </element-citation>
        </ref>
        <ref id="article-189.r32">
          <label>32</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kubala</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Hermida</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Nadji</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Quenum</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Traulle</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Jarry</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Normal pulmonary veins anatomy is associated with better AF-free survival after cryoablation as compared to atypical anatomy with common left pulmonary vein.</article-title>
            <source>Pacing Clin Electrophysiol</source>
            <year>2011</year>
            <month>Jul</month>
            <volume>34</volume>
            <issue>7</issue>
            <fpage>837</fpage>
            <page-range>837-43</page-range>
            <pub-id pub-id-type="pmid">21418249</pub-id>
          </element-citation>
        </ref>
        <ref id="article-189.r33">
          <label>33</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Khoueiry</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Albenque</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Providencia</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Combes</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Combes</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Jourda</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Sousa</surname>
                <given-names>PA</given-names>
              </name>
              <name>
                <surname>Cardin</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Pasquie</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Cung</surname>
                <given-names>TT</given-names>
              </name>
              <name>
                <surname>Massin</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Marijon</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Boveda</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Outcomes after cryoablation vs. radiofrequency in patients with paroxysmal atrial fibrillation: impact of pulmonary veins anatomy.</article-title>
            <source>Europace</source>
            <year>2016</year>
            <month>Sep</month>
            <volume>18</volume>
            <issue>9</issue>
            <fpage>1343</fpage>
            <page-range>1343-51</page-range>
            <pub-id pub-id-type="pmid">26817755</pub-id>
          </element-citation>
        </ref>
        <ref id="article-189.r34">
          <label>34</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sorgente</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Chierchia</surname>
                <given-names>GB</given-names>
              </name>
              <name>
                <surname>de Asmundis</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Sarkozy</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Namdar</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Capulzini</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Yazaki</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>M&#x000fc;ller-Burri</surname>
                <given-names>SA</given-names>
              </name>
              <name>
                <surname>Bayrak</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Brugada</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Pulmonary vein ostium shape and orientation as possible predictors of occlusion in patients with drug-refractory paroxysmal atrial fibrillation undergoing cryoballoon ablation.</article-title>
            <source>Europace</source>
            <year>2011</year>
            <month>Feb</month>
            <volume>13</volume>
            <issue>2</issue>
            <fpage>205</fpage>
            <page-range>205-12</page-range>
            <pub-id pub-id-type="pmid">20974756</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
